Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin M Spithoven

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Kidney360|April 4, 2022
Unilateral Pleural Effusion in a Hemodialysis PatientEdwin M Spithoven, Alferso C Abrahams
Kidney International|July 1, 2015
The Authors ReplyEdwin M Spithoven, Ron T Gansevoort
Case Reports in Nephrology and Urology|July 17, 2014
Nephrectomy in autosomal dominant polycystic kidney disease: a patient with exceptionally large, still functioning kidneysEdwin M Spithoven, Niek F Casteleijn, Paul Berger, et al.
BMC Family Practice|December 12, 2012
Cardiovascular screening in general practice in a low SES areaAns H Tiessen, Andries J Smit, Sebes Zevenhuizen, et al.
Kidney International Reports|August 24, 2019
Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKDA Lianne Messchendorp, Bart J Kramers, Edwin M Spithoven, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 9, 2014
Bilateral cysts in the choroid plexus in a patient with autosomal dominant polycystic kidney diseaseNiek F Casteleijn, Edwin M Spithoven, Maarten B Rookmaaker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 30, 2013
Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equationsEdwin M Spithoven, Esther Meijer, Wendy E Boertien, et al.
American Journal of Nephrology|May 1, 2015
Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?Niek F Casteleijn, Debbie Zittema, Stephan J L Bakker, et al.
BMC Nephrology|December 21, 2018
Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney diseaseA Lianne Messchendorp, Edwin M Spithoven, Niek F Casteleijn, et al.
Kidney International Reports|May 5, 2018
Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease ProgressionA Lianne Messchendorp, Esther Meijer, Wendy E Boertien, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Kidney360|April 4, 2022
Unilateral Pleural Effusion in a Hemodialysis PatientEdwin M Spithoven, Alferso C Abrahams
Kidney International|July 1, 2015
The Authors ReplyEdwin M Spithoven, Ron T Gansevoort
Case Reports in Nephrology and Urology|July 17, 2014
Nephrectomy in autosomal dominant polycystic kidney disease: a patient with exceptionally large, still functioning kidneysEdwin M Spithoven, Niek F Casteleijn, Paul Berger, et al.
BMC Family Practice|December 12, 2012
Cardiovascular screening in general practice in a low SES areaAns H Tiessen, Andries J Smit, Sebes Zevenhuizen, et al.
Kidney International Reports|August 24, 2019
Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKDA Lianne Messchendorp, Bart J Kramers, Edwin M Spithoven, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 9, 2014
Bilateral cysts in the choroid plexus in a patient with autosomal dominant polycystic kidney diseaseNiek F Casteleijn, Edwin M Spithoven, Maarten B Rookmaaker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 30, 2013
Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equationsEdwin M Spithoven, Esther Meijer, Wendy E Boertien, et al.
American Journal of Nephrology|May 1, 2015
Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?Niek F Casteleijn, Debbie Zittema, Stephan J L Bakker, et al.
BMC Nephrology|December 21, 2018
Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney diseaseA Lianne Messchendorp, Edwin M Spithoven, Niek F Casteleijn, et al.
Kidney International Reports|May 5, 2018
Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease ProgressionA Lianne Messchendorp, Esther Meijer, Wendy E Boertien, et al.
Pageof 3